Sunday, November 22, 2015

Diabetic Macular Edema Best Treated with Injections


Diabetic Macular Edema (DME) is a significant cause of vision loss in patients with diabetes and diabetic retinopathy. Retinal laser photocoagulation has been the standard treatment for DME for nearly 30 years decades but now there is evidence that better vision outcomes can be achieved with Vascular Endothelial Growth Factor (VEGF) Inhibitor injections such as Lucentis® or Eylea®. According to researchers reporting in the American Journal of Ophthalmology reviewing and publishing an analysis of studies on Diabetic Maculopathy published between January 1, 1985 and July 31, 2013, the number of patients with DME gaining an improvement of seeing an additional 10-15 letters on the eye chart was at least 2 times greater for those patients treated with the VEGF Inhibitor injections as compared to being treated with laser treatments. Thus, the researchers concluded that anti-VEGF therapy is superior to laser photocoagulation for treatment of moderate to severe visual impairment caused by DME.

If you or someone you know has diabetes and is concerned about their risk of Diabetic Macular Edema (DME) or Diabetic Retinopathy, it is critical that they have regular dilated eye exams. Please call Northwest Indiana Eye & Laser Center at 219-464-8223, or visit Northwest Indiana Eye & Laser Center, Google or facebook.com/nwindianaeyeandlaser to schedule an appointment.

Northwest Indiana Eye & Laser Center offices are located at 502 Marquette Street, Valparaiso, Indiana 46383 and 1001 South Edgewood Drive, Knox, Indiana 46354.